SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Immunomic Therapeutics Receives IND Authorization for Phase I Study of JRC-LAMP-Vax Vaccine to Treat Japanese Red Cedar (Sugi) Allergy